Intraperitoneal administration of 340 kDa human plasma butyrylcholinesterase increases the level of the enzyme in the cerebrospinal fluid of rats

Javier Sáez-Valero, José A. Pérez De Gracia, Oksana Lockridge

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Human butyrylcholinesterase (BuChE) is being developed as a new therapeutic for protection against the toxicity of organophosphorus agents and cocaine. The purified BuChE consists predominantly of 340 kDa tetramers and contains less than 5% monomers and dimers. Our goal was to determine whether BuChE crosses the blood-cerebrospinal fluid (CSF) barrier. Rats were injected intraperitoneally with 1 mg of purified human BuChE. Plasma BuChE activity increased nearly 400-fold, while BuChE activity in the CSF increased three-fold. Sucrose density centrifugation showed that the human BuChE molecule in the rat CSF was a tetramer. Immunoprecipitation confirmed the identity of the CSF BuChE as human BuChE. The lower amount of human BuChE in the CSF (0.04%) than of smaller proteins (0.1-1%), with respect to their levels in plasma, supports the idea that passage through the blood-CSF barrier depends on molecular size. BuChE in the CSF could serve to protect the brain from the neurotoxicity of organophosphorus pesticides and cocaine.

Original languageEnglish (US)
Pages (from-to)93-98
Number of pages6
JournalNeuroscience Letters
Volume383
Issue number1-2
DOIs
StatePublished - Jul 22 2005

Fingerprint

Butyrylcholinesterase
Cerebrospinal Fluid
Enzymes
Cocaine
Centrifugation
Immunoprecipitation
Pesticides
Sucrose

Keywords

  • Butyrylcholinesterase
  • Cerebrospinal fluid
  • Neurotoxicity
  • Organophosphorus

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Intraperitoneal administration of 340 kDa human plasma butyrylcholinesterase increases the level of the enzyme in the cerebrospinal fluid of rats. / Sáez-Valero, Javier; Pérez De Gracia, José A.; Lockridge, Oksana.

In: Neuroscience Letters, Vol. 383, No. 1-2, 22.07.2005, p. 93-98.

Research output: Contribution to journalArticle

@article{ec33939c3cbf4b728ebb60521e710832,
title = "Intraperitoneal administration of 340 kDa human plasma butyrylcholinesterase increases the level of the enzyme in the cerebrospinal fluid of rats",
abstract = "Human butyrylcholinesterase (BuChE) is being developed as a new therapeutic for protection against the toxicity of organophosphorus agents and cocaine. The purified BuChE consists predominantly of 340 kDa tetramers and contains less than 5{\%} monomers and dimers. Our goal was to determine whether BuChE crosses the blood-cerebrospinal fluid (CSF) barrier. Rats were injected intraperitoneally with 1 mg of purified human BuChE. Plasma BuChE activity increased nearly 400-fold, while BuChE activity in the CSF increased three-fold. Sucrose density centrifugation showed that the human BuChE molecule in the rat CSF was a tetramer. Immunoprecipitation confirmed the identity of the CSF BuChE as human BuChE. The lower amount of human BuChE in the CSF (0.04{\%}) than of smaller proteins (0.1-1{\%}), with respect to their levels in plasma, supports the idea that passage through the blood-CSF barrier depends on molecular size. BuChE in the CSF could serve to protect the brain from the neurotoxicity of organophosphorus pesticides and cocaine.",
keywords = "Butyrylcholinesterase, Cerebrospinal fluid, Neurotoxicity, Organophosphorus",
author = "Javier S{\'a}ez-Valero and {P{\'e}rez De Gracia}, {Jos{\'e} A.} and Oksana Lockridge",
year = "2005",
month = "7",
day = "22",
doi = "10.1016/j.neulet.2005.03.045",
language = "English (US)",
volume = "383",
pages = "93--98",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - Intraperitoneal administration of 340 kDa human plasma butyrylcholinesterase increases the level of the enzyme in the cerebrospinal fluid of rats

AU - Sáez-Valero, Javier

AU - Pérez De Gracia, José A.

AU - Lockridge, Oksana

PY - 2005/7/22

Y1 - 2005/7/22

N2 - Human butyrylcholinesterase (BuChE) is being developed as a new therapeutic for protection against the toxicity of organophosphorus agents and cocaine. The purified BuChE consists predominantly of 340 kDa tetramers and contains less than 5% monomers and dimers. Our goal was to determine whether BuChE crosses the blood-cerebrospinal fluid (CSF) barrier. Rats were injected intraperitoneally with 1 mg of purified human BuChE. Plasma BuChE activity increased nearly 400-fold, while BuChE activity in the CSF increased three-fold. Sucrose density centrifugation showed that the human BuChE molecule in the rat CSF was a tetramer. Immunoprecipitation confirmed the identity of the CSF BuChE as human BuChE. The lower amount of human BuChE in the CSF (0.04%) than of smaller proteins (0.1-1%), with respect to their levels in plasma, supports the idea that passage through the blood-CSF barrier depends on molecular size. BuChE in the CSF could serve to protect the brain from the neurotoxicity of organophosphorus pesticides and cocaine.

AB - Human butyrylcholinesterase (BuChE) is being developed as a new therapeutic for protection against the toxicity of organophosphorus agents and cocaine. The purified BuChE consists predominantly of 340 kDa tetramers and contains less than 5% monomers and dimers. Our goal was to determine whether BuChE crosses the blood-cerebrospinal fluid (CSF) barrier. Rats were injected intraperitoneally with 1 mg of purified human BuChE. Plasma BuChE activity increased nearly 400-fold, while BuChE activity in the CSF increased three-fold. Sucrose density centrifugation showed that the human BuChE molecule in the rat CSF was a tetramer. Immunoprecipitation confirmed the identity of the CSF BuChE as human BuChE. The lower amount of human BuChE in the CSF (0.04%) than of smaller proteins (0.1-1%), with respect to their levels in plasma, supports the idea that passage through the blood-CSF barrier depends on molecular size. BuChE in the CSF could serve to protect the brain from the neurotoxicity of organophosphorus pesticides and cocaine.

KW - Butyrylcholinesterase

KW - Cerebrospinal fluid

KW - Neurotoxicity

KW - Organophosphorus

UR - http://www.scopus.com/inward/record.url?scp=20344377142&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20344377142&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2005.03.045

DO - 10.1016/j.neulet.2005.03.045

M3 - Article

VL - 383

SP - 93

EP - 98

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 1-2

ER -